Fiscal Year (FY) 2024 Funding Opportunity, 20672-20673 [2024-06229]
Download as PDF
<![CDATA[
20672
Federal Register / Vol. 89, No. 58 / Monday, March 25, 2024 / Notices
Open: May 31, 2024, 2:45 p.m. to 3:00 p.m.
Agenda: Whole-genome sequencing in
non-Alzheimer dementias: Progress,
opportunities, and request for cloud
resources (Concept) (Bryan J. Traynor, M.D.,
Ph.D., Senior Investigator, LNG).
Place: National Institute on Aging,
Biomedical Research Center, 251 Bayview
Blvd., Baltimore, MD 21224 (Hybrid).
Open: May 31, 2024, 3:00 p.m. to 3:15 p.m.
Agenda: Discussion.
Place: National Institute on Aging,
Biomedical Research Center, 251 Bayview
Blvd., Baltimore, MD 21224 (Hybrid).
Closed: May 31, 2024, 3:15 p.m. to 4:30
p.m.
Agenda: To review and evaluate executive
Session (Final discussion of all Principal
Investigators reviewed on all days.).
Place: National Institute on Aging,
Biomedical Research Center, 3C211/Virtual,
251 Bayview Blvd., Baltimore, MD 21224
(Hybrid).
Closed: May 31, 2024, 4:30 p.m. to 4:30
p.m.
Agenda: To review and evaluate adjourn.
Place: National Institute on Aging,
Biomedical Research Center, 3C211/Virtual,
251 Bayview Blvd., Baltimore, MD 21224
(Hybrid).
Contact Person: Luigi Ferrucci, M.D.,
Ph.D., Scientific Director, National Institute
on Aging, 251 Bayview Boulevard, Suite 100,
Room 4C225, Baltimore, MD 21224, 410–
558–8110, LF27Z@NIH.GOV.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: March 19, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
Dated: March 19, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Computational and other
Technologies.
Date: April 11, 2024.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Marie-Jose Belanger, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Rm. 6188,
MSC 7804, Bethesda, MD 20892, 301–435–
1267, belangerm@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
[FR Doc. 2024–06147 Filed 3–22–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
National Heart, Lung, and Blood
Institute; Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Heart, Lung,
and Blood Institute Special Emphasis
Panel, Mentored Career Development KAwards, March 28, 2024, 11 a.m. to 3
p.m., National Institutes of Health,
Rockledge 1, 6705 Rockledge Drive,
Bethesda, MD 20892, which was
published in the Federal Register on
February 20, 2024, FR Doc 2024–03384,
89 FR 12850.
The meeting is being amended due to
a change in time from 11 a.m.–3 p.m. to
10:30 a.m.–2:30 p.m. This meeting
format will be a video assisted, and is
closed to the public in accordance with
provisions set forth in sections
552b(c)(4) and 552b(c)(6).
VerDate Sep<11>2014
18:08 Mar 22, 2024
Jkt 262001
[FR Doc. 2024–06227 Filed 3–22–24; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
BILLING CODE 4140–01–P
Fiscal Year (FY) 2024 Funding
Opportunity
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
AGENCY:
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Dated: March 19, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–06215 Filed 3–22–24; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
Substance Abuse and Mental
Health Services Administration,
Department of Health and Human
Services (HHS).
ACTION: Notice of intent to award a
single source cooperative agreement to
the Community-Based, AdvocacyFocused, Data-Driven, CoalitionBuilding Association (CADCA).
This notice is to inform the
public that the Substance Abuse and
Mental Health Services Administration
(SAMHSA) intends to award up to
$675,000 per year for up to five (5) years
to the Community-Based, AdvocacyFocused, Data-Driven, CoalitionBuilding Association (CADCA). The
purpose of the award is to leverage
existing resources to expand SAMHSA’s
scope and prevention capacity; provide
training and technical assistance to state
and community prevention leaders,
including members of anti-drug
community coalitions from around the
country who are committed to
addressing the evolving needs of the
behavioral health field; and to promote
prevention workforce development. The
training and workforce development
activities supported through this
cooperative agreement include
SAMHSA’s Prevention Day and
SAMHSA’s participation in the annual
National Leadership Forum, the annual
Mid-Year Training Institute of CADCA,
and developing youth leaders across the
three conferences/events listed above.
FOR FURTHER INFORMATION CONTACT:
David Lamont Wilson, Public Health
Analyst, Substance Abuse and Mental
Health Services Administration, 5600
Fishers Lane, Rockville, MD 20857,
telephone 240–276–2588; email:
david.wilson@samhsa.hhs.gov.
SUPPLEMENTARY INFORMATION:
Funding Opportunity Title: FY 2024
National Anti-Drug Coalitions Training
and Workforce Development
Cooperative Agreement (Short Title:
Coalitions Training Cooperative
Agreement), Notice of Funding
Opportunity SP–24–003.
Assistance Listing Number: 93.243.
Authority: The Coalitions Training
Cooperative Agreement is authorized
under sections 509, 516 and 520A of the
Public Health Service Act, as amended.
Justification: Eligibility for this
funding is limited to CADCA. CADCA is
SUMMARY:
E:\FR\FM\25MRN1.SGM
25MRN1
Federal Register / Vol. 89, No. 58 / Monday, March 25, 2024 / Notices
the only national organization that
provides training and technical
assistance annually through a national
leadership conference for thousands of
members of community coalitions
dedicated to preventing substance use.
CADCA is currently the sole
organization that plays a major role in
helping to strengthen and develop the
nation’s prevention infrastructure of
anti-drug coalitions in support of
ongoing activities funded by SAMHSA’s
priority prevention grant programs. It is
the only identified organization that
currently meets this experience level to
successfully implement this grant and
has a national reach to over 5,000
identified anti-drug coalitions across the
country. This is not a formal request for
application. Funding will only be
provided to CADCA based on the
receipt of a satisfactory application and
associated budget that is approved by a
review group.
Dated: March 20, 2024.
Ann Ferrero,
Public Health Analyst.
BILLING CODE 4162–20–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
[OMB Control Number 1651–0022]
Agency Information Collection
Activities; Revision; Entry Summary
(CBP Form 7501)
U.S. Customs and Border
Protection (CBP), Department of
Homeland Security.
ACTION: 30-Day notice and request for
comments.
AGENCY:
The Department of Homeland
Security, U.S. Customs and Border
Protection (CBP) will be submitting the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995 (PRA). The
information collection is published in
the Federal Register to obtain comments
from the public and affected agencies.
DATES: Comments are encouraged and
must be submitted (no later than April
24, 2024) to be assured of consideration.
ADDRESSES: Written comments and/or
suggestions regarding the item(s)
contained in this notice should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Please write comments and/
or suggestions in English. Find this
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
18:08 Mar 22, 2024
FOR FURTHER INFORMATION CONTACT:
Requests for additional PRA information
should be directed to Seth Renkema,
Chief, Economic Impact Analysis
Branch, U.S. Customs and Border
Protection, Office of Trade, Regulations
and Rulings, 90 K Street NE, 10th Floor,
Washington, DC 20229–1177,
Telephone number 202–325–0056 or via
email CBP_PRA@cbp.dhs.gov. Please
note that the contact information
provided here is solely for questions
regarding this notice. Individuals
seeking information about other CBP
programs should contact the CBP
National Customer Service Center at
877–227–5511, (TTY) 1–800–877–8339,
or CBP website at https://www.cbp.
gov/.
CBP
invites the general public and other
Federal agencies to comment on the
proposed and/or continuing information
collections pursuant to the Paperwork
Reduction Act of 1995 (44 U.S.C. 3501
et seq.). This proposed information
collection was previously published in
the Federal Register (88 FR 24203) on
April 19, 2023, allowing for a 60-day
comment period. This notice allows for
an additional 30 days for public
comments. This process is conducted in
accordance with 5 CFR 1320.8. Written
comments and suggestions from the
public and affected agencies should
address one or more of the following
four points: (1) whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility; (2) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
suggestions to enhance the quality,
utility, and clarity of the information to
be collected; and (4) suggestions to
minimize the burden of the collection of
information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology, e.g., permitting
electronic submission of responses. The
comments that are submitted will be
summarized and included in the request
for approval. All comments will become
a matter of public record.
SUPPLEMENTARY INFORMATION:
[FR Doc. 2024–06229 Filed 3–22–24; 8:45 am]
VerDate Sep<11>2014
particular information collection by
selecting ‘‘Currently under 30-day
Review—Open for Public Comments’’ or
by using the search function.
Jkt 262001
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
20673
Overview of This Information
Collection
Title: Entry Summary.
OMB Number: 1651–0022.
Form Number: 7501.
Current Actions: Revision.
Type of Review: Revision.
Affected Public: Importer, importer’s
agent for each import transaction.
Abstract: CBP Form 7501, Entry
Summary, is used to identify
merchandise entering the commerce of
the United States, and to document the
amount of duty and/or tax paid. CBP
Form 7501 is submitted by the importer,
or the importer’s agent, for each import
transaction. The data on this form is
used by CBP as a record of the import
transaction; to collect the proper duty,
taxes, certifications, and enforcement
information; and to provide data to the
U.S. Census Bureau for statistical
purposes. CBP Form 7501 must be filed
within 10 working days from the time
of entry of merchandise into the United
States. Collection of the data on this
form is authorized by 19 U.S.C. 1484
and provided for by 19 CFR 141.61 and
19 CFR 142.11. CBP Form 7501 and
accompanying instructions can be found
at: https://www.cbp.gov/newsroom/
publications/forms?title_1=7501.
New Change
CBP is proposing to add the following
required data fields to Form 7501:
D For certain Harmonized Tariff
Schedule (HTS) classifications of steel
imports, the country where the steel
used in the manufacture of the product
was melted and poured; the country
where the steel used in the manufacture
of the product was melted and poured
applies to the original location where
the raw steel is first produced in a steelmaking furnace in a liquid state; and
then poured into its first solid shape.
D For certain HTS classifications of
aluminum imports, the countries where
the largest and second largest volume of
primary aluminum used in the
manufacture of the imported aluminum
product was smelted; and the country
where the aluminum used in the
imported aluminum product was most
recently cast. The fields requiring
identification of the countries where the
largest volume of primary aluminum
used in the manufacture of the product
was smelted applies to the country
where the largest volume of new
aluminum metal is produced from
alumina (or aluminum oxide) by the
electrolytic Hall-He´roult process.
Importers may be required to report if
primary aluminum from specific
countries is used in the imported
E:\FR\FM\25MRN1.SGM
25MRN1
]]>Agencies
[Federal Register Volume 89, Number 58 (Monday, March 25, 2024)]
[Notices]
[Pages 20672-20673]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-06229]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Fiscal Year (FY) 2024 Funding Opportunity
AGENCY: Substance Abuse and Mental Health Services Administration,
Department of Health and Human Services (HHS).
ACTION: Notice of intent to award a single source cooperative agreement
to the Community-Based, Advocacy-Focused, Data-Driven, Coalition-
Building Association (CADCA).
-----------------------------------------------------------------------
SUMMARY: This notice is to inform the public that the Substance Abuse
and Mental Health Services Administration (SAMHSA) intends to award up
to $675,000 per year for up to five (5) years to the Community-Based,
Advocacy-Focused, Data-Driven, Coalition-Building Association (CADCA).
The purpose of the award is to leverage existing resources to expand
SAMHSA's scope and prevention capacity; provide training and technical
assistance to state and community prevention leaders, including members
of anti-drug community coalitions from around the country who are
committed to addressing the evolving needs of the behavioral health
field; and to promote prevention workforce development. The training
and workforce development activities supported through this cooperative
agreement include SAMHSA's Prevention Day and SAMHSA's participation in
the annual National Leadership Forum, the annual Mid-Year Training
Institute of CADCA, and developing youth leaders across the three
conferences/events listed above.
FOR FURTHER INFORMATION CONTACT: David Lamont Wilson, Public Health
Analyst, Substance Abuse and Mental Health Services Administration,
5600 Fishers Lane, Rockville, MD 20857, telephone 240-276-2588; email:
[email protected].
SUPPLEMENTARY INFORMATION:
Funding Opportunity Title: FY 2024 National Anti-Drug Coalitions
Training and Workforce Development Cooperative Agreement (Short Title:
Coalitions Training Cooperative Agreement), Notice of Funding
Opportunity SP-24-003.
Assistance Listing Number: 93.243.
Authority: The Coalitions Training Cooperative Agreement is
authorized under sections 509, 516 and 520A of the Public Health
Service Act, as amended.
Justification: Eligibility for this funding is limited to CADCA.
CADCA is
[[Page 20673]]
the only national organization that provides training and technical
assistance annually through a national leadership conference for
thousands of members of community coalitions dedicated to preventing
substance use. CADCA is currently the sole organization that plays a
major role in helping to strengthen and develop the nation's prevention
infrastructure of anti-drug coalitions in support of ongoing activities
funded by SAMHSA's priority prevention grant programs. It is the only
identified organization that currently meets this experience level to
successfully implement this grant and has a national reach to over
5,000 identified anti-drug coalitions across the country. This is not a
formal request for application. Funding will only be provided to CADCA
based on the receipt of a satisfactory application and associated
budget that is approved by a review group.
Dated: March 20, 2024.
Ann Ferrero,
Public Health Analyst.
[FR Doc. 2024-06229 Filed 3-22-24; 8:45 am]
BILLING CODE 4162-20-P
